Crescent Biopharma, Inc. (CBIO)
NASDAQ·Healthcare·Biotechnology
$13.69
+1.13%
Mkt Cap $480.64M
Analyst Ratings
Buy
4
Hold
1
Sell
0
Price Target (7 analysts)
$36.00
Range $36.00 – $36.00
Implied Upside
+162.9%
Consensus $36.00 vs current $13.69
NASDAQ·Healthcare·Biotechnology
$13.69
+1.13%
Mkt Cap $480.64M
Buy
4
Hold
1
Sell
0
Price Target (7 analysts)
$36.00
Range $36.00 – $36.00
+162.9%
Consensus $36.00 vs current $13.69